Lenz, S; Ustjanzew, A; Jeray, M et al.
Few-Shot-Prompting von Large Language Models zur Extraktion von Daten zu Tumordiagnosen aus urologischen Arztbriefen – eine Evaluation2024
Rashedi, Sina; Greason, Christie M.; Sadeghipour, Parham et al.
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved IndicationsSEMINARS IN THROMBOSIS AND HEMOSTASIS. 2024
Roehrich, Manuel; Rosales, Juan J.; Hoppner, Jorge et al.
Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remissionRHEUMATOLOGY. Bd. 63. H. 9. 2024 S. 2473-2483
Wick, Wolfgang; Lanz, Lisa-Marie; Wick, Antje et al.
FINAL RESULTS FROM N2M2/NOA-20NEURO-ONCOLOGY. Bd. 26. 2024
Wilson, Stephanie M. G.; Oliver, Andrew; Larke, Jules A. et al.
Fine-Scale Dietary Polyphenol Intake Is Associated with Systemic and Gastrointestinal Inflammation in Healthy AdultsJOURNAL OF NUTRITION. Bd. 154. H. 11. 2024 S. 3286-3297
Fathallah, B.; Medina, M.; Duerr, G. D. et al.
First Case of a Failing Right Ventricle in a Patient with CCTGA Treated with Transvasal Microaxial Flow PumpJOURNAL OF HEART AND LUNG TRANSPLANTATION. Bd. 43. H. 4. 2024 S. S596-S596
Holtkamp, Martin; May, Theodor W.; Berkenfeld, Ralf et al.
First epileptic seizure and epilepsies in adulthoodCLINICAL EPILEPTOLOGY. Bd. 37. H. SUPPL 3. 2024 S. 87-107
Holtkamp, Martin; May, Theodor W.; Berkenfeld, Ralf et al.
First epileptic seizure and epilepsies in adulthood. Abridged version ofthe S2k guideline of the German Society for Neurology in cooperationwith the German Society for EpileptologyCLINICAL EPILEPTOLOGY. Bd. 37. H. 2. 2024 S. 118-139
Stiller, Hanna L.; Perumal, Natarajan; Manicam, Caroline et al.
First- vs. Second-Generation Autologous Platelet Concentrates and Their Implications for Wound Healing: Differences in Proteome and SecretomeBIOENGINEERING-BASEL. Bd. 11. H. 11. 2024
Janjigian, Yelena Y.; Ajani, Jaffer A.; Moehler, Markus et al.
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 TrialJOURNAL OF CLINICAL ONCOLOGY. Bd. 42. H. 17. 2024